Whalesbook
GPT Healthcare Limited has recommended a final dividend of ₹1.50 per equity share for the financial year 2025-26. This proposed payout represents a significant increase from the ₹1.00 per share dividend recommended for fiscal year 2023-24, marking a 50% rise.
Shareholder approval for this increased dividend is required and will be sought at the company's 37th Annual General Meeting (AGM). The AGM is scheduled to be held via Video Conferencing on August 6, 2026. The company has also set July 30, 2026, as the record date to determine who is entitled to the dividend and for the AGM quorum.
The board's recommendation to increase the dividend often signals management's confidence in the company's financial health and its future earnings prospects. For investors, the proposed higher dividend offers a direct return on their investment.
GPT Healthcare's proposed dividend increase aligns with trends among its larger healthcare peers. For comparison, Apollo Hospitals declared an interim dividend of ₹20 for FY24, while Fortis Healthcare and Max Healthcare each recommended ₹2 per share for the same period. The proposed payout from GPT Healthcare reflects its growing capacity to return capital to shareholders.
If shareholders approve the dividend at the AGM, the company is expected to distribute the payout within 30 days following the meeting. The primary risk to the distribution is shareholder non-approval at the AGM, though this is uncommon for standard dividend recommendations. Future dividend policies may also be influenced by the company's ongoing financial performance.
GPT Healthcare, which operates hospitals and pharmacies primarily in Eastern India, completed its Initial Public Offering (IPO) in December 2023.